Skip to main content

Table 2 Prevalence of PCV13 serotypes in Western European countries in children <5 years of age. For details on local vaccine use, please see text

From: Pneumococcal serotype evolution in Western Europe

  Age (year) Post-PCV7 period Three most prevalent serotypes Post-higher valent PCV periods Three most prevalent serotypes
Year Among all IPD, % Year Among all IPD, %
Countries in which only PCV13 used
Belgium [11] <5 2010 73 19A, 1, 7 F 2013 36 1, 12 F, 24 F
France [20] <2 2009 71 19A, 7 F, 1 2012 24 24 F, 12 F, 15B/C
Italy [24] <5 2011 64 1, 19A, 22 F 2014 37 19A, 1, 24 F
Norway [25] <5 2010 61 19A, 1, 7 F 2012 26 1, 15B/C
Switzerland [29] <2 2010–2011 68 3, 19A, 7 F 2012 53 3, 23 (not 23 F), 19 F
UK [31] <5 2008–2010 68 7 F, 19A, 1 2013–2014 15 24 F, 22 F, 33 F
Countries in which only PCV10 used
Austria [33, 37] <5 2009 73 3, 14, 18C 2013 93 19A, 7 F, 23 F
Finland [39] <5 2010 92 14, 6B, 19 F 2014 70 19A, 3, 7 F, 23A
Countries in which both PCV13 and PCV10 used
Germanya [44] <16 2008–2009 56 7 F, 1, 18Cb 2012–2013 12 7 F, 10A, 19Ac
Sweden [45] <2 2009 84 22 F, 7 F, 3, 19A 2012 47 33 F, 11
  1. aPneumococcal meningitis; b2007–2010; c2010–2013